Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ascendis Health

Ascendis Health
2008 FOUNDED
PUBLIC STATUS
ASC STOCK SYMBOL
19 INVESTMENTS
$0.20 SHARE PRICE (As of Wednesday Closing)
Description

Ascendis Health Limited is drug manufacturer that produces and distributes health products for the human, animal, and plant markets. Ascendis Health has four segments: Phyto-Vet, Consumer Brands, Pharma-Med, and International. The Phyto-Vet segment supplies health and care products to the plants and animal market. The Consumer brands segment sells vitamins and minerals, ayurvedic products, herbal products, weight management products, and sports nutritional supplements. The Pharma-Med segment provides prescription medicine and medical devices. The International segment sells the aforementioned products abroad. The company earns the majority of its revenue in South Africa.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Stock Exchange
JSE
Primary Office
  • PostNet, Suite 252, Private Bag X21
  • Johannesburg, Gauteng 2191
  • South Africa

+27 011 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ascendis Health’s full profile, request a free trial.

Ascendis Health Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.20 - $0.47 $98.4M $0.20 -$0.68 204K 485M

Ascendis Health Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
30-Jun-2019
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
Enterprise Value 540,439 540,439 773,956 989,253
Revenue 361,341 361,341 391,499 470,216
EBITDA (285,072) (285,072) 56,171 66,809
Net Income (328,705) (328,705) 20,006 20,773
Total Assets 798,643 798,643 1,149,634 1,117,403
Total Debt 392,285 392,285 407,175 397,037
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ascendis Health Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Ascendis Health‘s full profile, request access.

Request full access to PitchBook

Ascendis Health Investments & Acquisitions (19)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 0000 000000 02-Jun-2017 000000000000000000 000.00 Pharmaceuticals 0000000 0000000 00.0
000 0000000 000000 01-Jun-2017 000000000000000000 000.00 Pharmaceuticals 0000000 0000000 00.0
00000 (00000 00000 01-Apr-2017 000000000000000000 000.00 Pharmaceuticals
000000 000000000 26-Aug-2016 000000000000000000 00000 Beverages 0000000 0000000 00.0
Remedica 25-Aug-2016 Merger/Acquisition 00000 Pharmaceuticals 0000000 0000000 00.0
To view this company’s complete investment and acquisition history, request access »

Ascendis Health Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 01-Feb-2016 000000000000000000 000.00 Completed
  • 00000000 000000
Efekto 01-Sep-2011 Buyout/LBO Completed
  • 4 buyers
To view this company’s complete exits history, request access »

Ascendis Health Subsidiaries (10)

Company Name Industry Location Founded
SOLAL Technologies Food Products Johannesburg, South Africa 2009
0000000000 000000 Other Pharmaceuticals and Biotechnology Umhlanga Rocks, South Africa 0000
000 0000 000000 Pharmaceuticals Bucuresti, Romania 0000
00000000000 0000 0 Medical Supplies Johannesburg, South Africa 0000
000000 000000000 Beverages Orlando, FL 0000
To view this company’s complete subsidiary history, request access »

Ascendis Health Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Ascendis Health‘s full profile, request access.

Request full access to PitchBook

Ascendis Health Executive Team (5)

Name Title Board
Seat
Contact
Info
Thomas Thomsen Chief Executive Officer & Executive Director
Kieron Futter Chief Financial Officer
Andy Sims Company Secretary & Chief Risk Officer

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »